July 17, 2020 Sci Immunol. Resistance to PD1 blockade in the absence of metalloprotease-mediated LAG3 shedding
Andrews LP, Somasundaram A, Moskovitz JM, Szymczak-Workman AL, Liu C, Cillo AR, Lin H, Normolle DP, Moynihan KD, Taniuchi I, Irvine DJ, Kirkwood JM, Lipson EJ, Ferris RL, Bruno TC, Workman CJ, Vignali DAA.
July 15, 2020 J Immunother Cancer Neuropilin-1: a checkpoint target with unique implications for cancer immunology and immunotherapy June 30, 2020 Curr Opin Immunol. Inhibitory receptor agonists: the future of autoimmune disease therapeutics? February 05, 2020 Cancer Immunol Res. B cell-Derived IL35 Drives STAT3-Dependent CD8 + T-cell Exclusion in Pancreatic Cancer
Mirlekar B, Michaud D, Lee SJ, Kren NP, Harris C, Greene K, Goldman EC, Gupta GP, Fields RC, Hawkins WG, DeNardo DG, Rashid NU, Yeh JJ, McRee AJ, Vincent BG, Vignali DAA and Pylayeva-Gupta Y.
January 28, 2020 Cell Rep. Treg-Cell-Derived IL-35-Coated Extracellular Vesicles Promote Infectious Tolerance.
Sullivan JA, Tomita Y, Jankowska-Gan E, Lema DA, Arvedson MP, Nair A, Bracamonte-Baran W, Zhou Y, Meyer KK, Zhong W, Sawant DV, Szymczak-Workman AL, Zhang Q, Workman CJ, Hong S, Vignali DAA, Burlingham WJ.
January 14, 2020 Immunity Immune Landscape of Viral- and Carcinogen-Driven Head and Neck Cancer.